0001441844-11-000018.txt : 20110504
0001441844-11-000018.hdr.sgml : 20110504
20110504153013
ACCESSION NUMBER: 0001441844-11-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110502
FILED AS OF DATE: 20110504
DATE AS OF CHANGE: 20110504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ISRAEL ROBERT J
CENTRAL INDEX KEY: 0001250274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 11810094
MAIL ADDRESS:
STREET 1: 50 OXFORD DR
CITY: MONTEBELLE
STATE: NY
ZIP: 10901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0303
4
2011-05-02
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001250274
ISRAEL ROBERT J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
Sr. VP, Medical Affairs
Common Stock
2011-05-02
4
M
0
1000
5.33
A
45040
D
Common Stock
2011-05-02
4
S
0
1000
7.39
D
44040
D
Non-Qualified Stock Option (right to buy)
5.33
2011-05-02
4
M
0
1000
0
D
2010-07-01
2019-07-01
Common Stock
1000
39000
D
The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
This transaction was executed in multiple trades at prices ranging from $7.31 to $7.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The stock options become exercisable in three equal installments, commencing one year from the grant date.
By: Robert A. McKinney For: Robert J. Israel
2011-05-04